Bangalore Medical College and Research Institute

Bangalore, Karnataka 560002

0 studies enrolling now · 4 studies all time

What they study most

COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2, Type 2 Diabetes Mellitus, Ulcerative Colitis

Studies at this site

• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone — Completed